These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Techniques of continuous arteriovenous hemofiltration and hemodialysis. Renal replacement in the ICU for hypervolemic, uremic patients. Merrill RH J Crit Illn; 1991 Apr; 6(4):381-7. PubMed ID: 10147916 [TBL] [Abstract][Full Text] [Related]
3. Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood. Schaefer K; von Herrath D; Gullberg CA; Asmus G; Hüfler M; Offermann G; Cremer H; Heuck CC; Ritz E Artif Organs; 1978 Nov; 2(4):386-94. PubMed ID: 743012 [TBL] [Abstract][Full Text] [Related]
4. Paired filtration-dialysis (PFD): a separate convective-diffusive system for extracorporeal blood purification in uraemic patients. Ghezzi PM; Zucchelli P; Ringoir S; Nigrelli S; Santoro A; Gervasio R; Sanz Moreno C; Vanholder R; Botella J Adv Exp Med Biol; 1987; 223():267-75. PubMed ID: 3328955 [No Abstract] [Full Text] [Related]
5. Lipid metabolism in uremia: effect of regular hemofiltration and hemodialysis treatment. Henning HV; Balusek E J Dial; 1977; 1(6):595-605. PubMed ID: 608870 [TBL] [Abstract][Full Text] [Related]
6. Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness. Gibney RT; Stollery DE; Lefebvre RE; Sharun CJ; Chan P CMAJ; 1988 Nov; 139(9):861-6. PubMed ID: 3179891 [TBL] [Abstract][Full Text] [Related]
7. Continuous arteriovenous renal replacement therapy. Zobel G; Ring E; Trop M Int J Artif Organs; 1987 Jul; 10(4):241-4. PubMed ID: 3666977 [TBL] [Abstract][Full Text] [Related]
8. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment]. Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056 [No Abstract] [Full Text] [Related]
9. Hemodialysis and the elderly patient: potential advantages as to quality of life, urea generation, serum creatinine, and less interdialytic weight gain. Avram MR; Pena C; Burrell D; Antignani A; Avram MM Am J Kidney Dis; 1990 Oct; 16(4):342-5. PubMed ID: 2220783 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic simulation of different modes of renal replacement therapy]. Iakovleva II; Timokhov VS Anesteziol Reanimatol; 2004; (6):16-23. PubMed ID: 15717511 [TBL] [Abstract][Full Text] [Related]